37120111000001101: Memantine 10mg tablets (Mawdsley-Brooks & Company Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Memantine 10mg tablets (Mawdsley-Brooks & Company Ltd)
\UK product\Virtual medicinal product\Product containing precisely memantine hydrochloride 10 milligram/1 each conventional release oral tablet\Memantine 10mg tablets (Mawdsley-Brooks & Company Ltd)
\UK product\Virtual therapeutic moiety\Memantine\Product containing only memantine in oral dose form (medicinal product form)\Product containing precisely memantine hydrochloride 10 milligram/1 each conventional release oral tablet\Memantine 10mg tablets (Mawdsley-Brooks & Company Ltd)
\UK product\Virtual therapeutic moiety\Memantine\Product containing precisely memantine hydrochloride 10 milligram/1 each conventional release oral tablet\Memantine 10mg tablets (Mawdsley-Brooks & Company Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing N-methyl-D-aspartate receptor antagonist product receptor antagonist\Product containing memantine\Memantine\Product containing only memantine in oral dose form (medicinal product form)\Product containing precisely memantine hydrochloride 10 milligram/1 each conventional release oral tablet\Memantine 10mg tablets (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing N-methyl-D-aspartate receptor antagonist product receptor antagonist\Product containing memantine\Memantine\Product containing precisely memantine hydrochloride 10 milligram/1 each conventional release oral tablet\Memantine 10mg tablets (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing N-methyl-D-aspartate receptor antagonist product receptor antagonist\Product containing memantine\Product containing memantine in oral dose form (medicinal product form)\Product containing only memantine in oral dose form (medicinal product form)\Product containing precisely memantine hydrochloride 10 milligram/1 each conventional release oral tablet\Memantine 10mg tablets (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing memantine\Memantine\Product containing only memantine in oral dose form (medicinal product form)\Product containing precisely memantine hydrochloride 10 milligram/1 each conventional release oral tablet\Memantine 10mg tablets (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing memantine\Memantine\Product containing precisely memantine hydrochloride 10 milligram/1 each conventional release oral tablet\Memantine 10mg tablets (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing memantine\Product containing memantine in oral dose form (medicinal product form)\Product containing only memantine in oral dose form (medicinal product form)\Product containing precisely memantine hydrochloride 10 milligram/1 each conventional release oral tablet\Memantine 10mg tablets (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antidementia agent (product)\Product containing memantine in oral dose form (medicinal product form)\Product containing only memantine in oral dose form (medicinal product form)\Product containing precisely memantine hydrochloride 10 milligram/1 each conventional release oral tablet\Memantine 10mg tablets (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing memantine in oral dose form (medicinal product form)\Product containing only memantine in oral dose form (medicinal product form)\Product containing precisely memantine hydrochloride 10 milligram/1 each conventional release oral tablet\Memantine 10mg tablets (Mawdsley-Brooks & Company Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 15-May 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

164261000001111 Memantine 10mg tablets (Mawdsley-Brooks & Company Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

164271000001118 Memantine 10mg tablets (Mawdsley-Brooks & Company Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Memantine 10mg tablets (Mawdsley-Brooks & Company Ltd)	Is a	Product containing precisely memantine hydrochloride 10 milligram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Memantine 10mg tablets (Mawdsley-Brooks & Company Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Memantine 10mg tablets (Mawdsley-Brooks & Company Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Memantine 10mg tablets (Mawdsley-Brooks & Company Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Memantine 10mg tablets (Mawdsley-Brooks & Company Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Memantine 10mg tablets (Mawdsley-Brooks & Company Ltd)	Has specific active ingredient	Memantine hydrochloride	true	Inferred relationship	Existential restriction modifier
Memantine 10mg tablets (Mawdsley-Brooks & Company Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Memantine 10mg tablets (Mawdsley-Brooks & Company Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Memantine 10mg tablets (Mawdsley-Brooks & Company Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Memantine 10mg tablets (Mawdsley-Brooks & Company Ltd) 56 tablet	Has AMP	True	Memantine 10mg tablets (Mawdsley-Brooks & Company Ltd)	Inferred relationship	Existential restriction modifier
Memantine 10mg tablets (Mawdsley-Brooks & Company Ltd) 28 tablet	Has AMP	True	Memantine 10mg tablets (Mawdsley-Brooks & Company Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
164261000001111	Memantine 10mg tablets (Mawdsley-Brooks & Company Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
164271000001118	Memantine 10mg tablets (Mawdsley-Brooks & Company Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module